/PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with.
MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience
News provided by
Share this article
Psychedelic Pharmaceutical Scientist and Clinical Pharmacologist Robert Barrow Appointed as Chief Development Officer
NEW YORK, Jan. 14, 2021 /PRNewswire/ MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced the addition of Robert Barrow, an accomplished pharmaceutical executive, as Chief Development Officer. Mr. Barrow has over a decade of experience leading drug development programs aimed at identifying and testing novel treatments in a wide range of disease conditions under FDA and EMA.
In his most recent position, Mr. Barrow served as Director of Drug Development & Discovery at the Usona Institute, where he oversaw preclinical, clinical and regulatory development efforts for all of Usona s development programs in psychedelics. At Usona, Mr. Barrow was responsible for launching the Phase 2
Share this article
Share this article
SAN DIEGO, Jan. 14, 2021 /PRNewswire/ Cortechs.ai is pleased to announce the appointment of its new vice president of sales, Josh Cohen. The new appointment follows the acquisition of sister company Healthlytix and a company rebrand from CorTechs Labs to Cortechs.ai. Cortechs.ai is a leader in AI applications in radiology with FDA-cleared products for improved detection of neurodegenerative disease and cancer.
Josh brings over 12 years of proven commercial sales and leadership success. With expertise in business development and sales strategies in both large hospital health systems and outside the hospital space, Josh has a deep focus on integrated radiology solutions, informatics, and artificial intelligence to help healthcare providers deliver improved outcomes at a lower cost.
Tikcro Technologies Reports Third Quarter 2020 Results
USA - English
Share this article
Share this article
HADERA, Israel, Jan. 14, 2021 /PRNewswire/ Tikcro Technologies Ltd. (OTCQB: TIKRF), today reported its financial results for the third quarter ended September 30, 2020. We continue to consider businesses for a reverse merger and other corporate alternatives, said Aviv Boim, CEO of Tikcro.
Financial Results for the Third Quarter Ended September 30, 2020
Net loss for the second quarter of 2020 was $132,000, or $0.01 per diluted share, compared to a net loss of $237,000, or $0.02 per diluted share, for the same period last year.
As of September 30, 2020, the company reported $4.0 million in cash, cash equivalents and short-term bank deposits.
International Artist Romero Britto Partners With PHIT America LET s GET KIDS TO PLAY Campaign & $10,000 Coloring Book Contest
News provided by
Share this article
Share this article
WASHINGTON, Jan. 14, 2021 /PRNewswire/ BRITTO, PHIT America and its partners will be promoting a series of BRITTO designed sport and fitness images in the
$10,000 BRITTO Coloring Contest to shine a spotlight on the need to get kids active and moving for better health and happiness.
Join Romero Britto and PHIT America in helping to get kids active, happy and healthy! Get involved and show support at PHITKids.org.
PHIT America, whose mission is to improve the physical and mental health of children through physical activity, will be teaming with partners like the Julia Love Pritt Private Foundation and 20 companies from the sports and fitness industry to promote